文献速递免疫规划

评估牛BCG攻击模型的敏感性:采用初免-加强Ad85A疫苗方案

Evaluating the sensitivity of the bovine BCG challenge model using a prime boost Ad85A vaccine regimen.
PubMed 文献 · Vaccine · 2019-11-20

研究旨在评估牛BCG攻击模型的敏感性,采用先前在牛分枝杆菌攻击中优于单独BCG的初免-加强方案(BCG Danish皮下接种后以表达抗原85A的重组腺病毒载体Ad85A加强),所有动物经肩前淋巴结攻击BCG Tokyo并检测淋巴结内细菌载量。所有接种动物清除BCG均显著快于对照,但BCG与BCG-Ad85A方案间无差异;培养ELISpot显示受保护接种动物的IFN-ɣ反应显著高于对照。

要点

  • 所有接种动物清除淋巴结内BCG显著快于对照,提示保护效应。
  • BCG与BCG-Ad85A方案间无差异。
  • 培养ELISpot显示受保护接种动物IFN-ɣ反应显著高于对照。

核心结论

  • 牛BCG攻击模型可检测疫苗保护效应,且所有接种动物清除BCG显著快于对照,但BCG与BCG-Ad85A方案间无差异。
  • 该模型可作为牛分枝杆菌攻击模型的替代方案,用于发现保护性生物标志物。

研究设计与样本

  • 研究评估牛BCG攻击模型的敏感性,采用初免-加强疫苗方案进行攻击实验。
  • 除对照组外所有动物皮下接种BCG Danish,其中一半随后以表达抗原85A的重组腺病毒载体Ad85A加强。
  • 所有动物经肩前淋巴结攻击BCG Tokyo,并检测淋巴结内细菌载量。

主要发现

  • 所有接种动物(无论接种方案)清除淋巴结内BCG显著快于对照动物,提示保护效应。
  • BCG与BCG-Ad85A方案间无差异。
  • 培养ELISpot显示受保护接种动物的IFN-ɣ反应显著高于对照,而未受保护接种动物无此差异。
  • 定量PCR和细胞内染色观察到受保护动物产生更多IFN-ɣ的趋势。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In the absence of biomarkers of protective immunity, newly developed vaccines against bovine tuberculosis need to be evaluated in virulent Mycobacterium bovis challenge experiments, which require the use of expensive and highly in demand Biological Safety Level 3 (BSL3) animal facilities. The recently developed bovine BCG challenge model offers a cheaper and faster way to test new vaccine candidates and additionally reduces the severity of the challenge compared to virulent M. bovis challenge in line with the remits of the NC3Rs. In this work we sought to establish the sensitivity of the BCG challenge model by testing a prime boost vaccine regimen that previously increased protection over BCG alone against M. bovis challenge. All animals, except the control group, were vaccinated subcutaneously with BCG Danish, and half of those were then boosted with a recombinant adenoviral vector expressing Antigen 85A, Ad85A. All animals were challenged with BCG Tokyo into the prescapular lymph node and the bacterial load within the lymph nodes was established. All vaccinated animals, independent of the vaccination regimen, cleared BCG significantly faster from the lymph node than control animals, suggesting a protective effect. There was however, no difference between the BCG and the BCG-Ad85A regimens. Additionally, we analysed humoral and cellular immune responses taken prior to challenge for possible predictors of protection. Cultured ELISpot identified significantly higher IFN-ɣ responses in protected vaccinated animals, relative to controls, but not in unprotected vaccinated animals. Furthermore, a trend for protected animals to produce more IFN-ɣ by quantitative PCR and intracellular staining was observed. Thus, this model can also be an attractive alternative to M. bovis challenge models for the discovery of protective biomarkers.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Biffar L, Blunt L, Atkins W, et al. Evaluating the sensitivity of the bovine BCG challenge model using a prime boost Ad85A vaccine regimen. Vaccine. 2019. PMID: 31759733. doi:10.1016/j.vaccine.2019.11.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。